MA, A. et al. 2026. DISCOVERY OF POTENTIAL GSK-3β INHIBITORS AGAINST ALZHEIMER’S DISEASE: IN SILICO DESIGN AND PHARMACOKINETIC EVALUATION OF N-(ANTHRACENE-1-YL)-2-PHENOXYACETAMIDE ANALOGS. International Journal of Applied Pharmaceutics. 18, 4 (Apr. 2026). DOI:https://doi.org/10.22159/ijap.2026v18i4.58331.